CICR Communications Subcommittee
![William Zuercher, PhD](https://www.aacr.org/wp-content/uploads/2022/11/Zuercher_Bill_145x145.jpg)
William Zuercher, PhD
(2022-2024) Senior Principal Scientist
Roche Pharma Research and Early Development
Roche Innovation Center Basel
Basel, Switzerland
![Milka Kostic, PhD](https://www.aacr.org/wp-content/uploads/2022/06/Kostic_Milka_145x145.jpg)
Milka Kostic, PhD
(2022-2024)Program Director, Chemical Biology
Training Curriculum Director, Cancer Chemical Biology and Metabolism
Department of Cancer Biology
Dana-Farber Cancer Institute
Boston, Massachusetts
![Dennis X. Hu, PhD](https://www.aacr.org/wp-content/uploads/2021/08/Heads_EXE_WG_SC_Hu_Addit_HS_145x145_2107042B_1.jpg)
Dennis X. Hu, PhD
(2021-2023)Senior Scientist, Small Molecule Drug Discovery
Genentech
South San Francisco, California
![Lyn Howard Jones, PhD](https://www.aacr.org/wp-content/uploads/2021/04/Heads_EXE_CICR_SubCom_Lyn-Jones_145x145_2104046_1.jpg)
Lyn Howard Jones, PhD
(2021-2023)Chief Scientist, Center for Protein Degradation
Dana-Farber Cancer Institute
Boston, Massachusetts
Barbara Czako, PhD
(2021-2023)Principal Scientist, Therapeutics Discovery
MD Anderson Cancer Center
Houston, Texas
Martin E. Swarbrick, PhD
(2022-2024)Director of R&D Chemistry
Ryvu Therapeutics SA
Krakow, Poland
Keith R. Hornberger, PhD
(2022-2023)Director, Chemistry
Arvinas, Inc.
New Haven, Connecticut